Navigation Links
SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models
Date:5/19/2009

ion. SemBioSys' proprietary safflower derived Apo AI(Milano) is a des I, 2 variant of Apo AI(Milano) as previously described in the literature.

About SemBioSys

Calgary, Alberta-based SemBioSys is a world leader in manufacturing high-value proteins and oils in plant seeds. With its unique proprietary platform, SemBioSys provides partners with product enablement, exceptionally low cost and unprecedented scalability. The Company applies this platform with high selectivity to opportunities where it has a unique competitive advantage. Since its inception, SemBioSys has produced more than 50 non-native proteins and oils using its patented seed technology, demonstrating applicability across a broad range of industries such as pharmaceuticals, personal care and industrial products. The Company's current pharmaceutical development programs include insulin (SBS-1000, regulated as a biosimilar in Europe) and Apo AI(Milano), a next-generation cardiovascular therapy. SemBioSys is listed on the Toronto Stock Exchange under the ticker SBS. More information is available at www.sembiosys.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and other similar expressions which constitute "forward-looking information" within the meaning of applicable securities laws. Forward-looking statements reflect the Company's current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, changing market conditions and market size, the acceptance of an IND by the FDA in respect of clinical studies, the submission of a CTA to the a
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC
2. SemBioSys provides update on insulin program
3. SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin
4. SemBioSys announces senior management changes
5. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
6. SemBioSys begins phase I/II trial of insulin produced in plant seeds
7. SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
8. SemBioSys announces second quarter 2008 financial and operational results
9. SemBioSys submits IND for safflower-produced insulin to U.S. FDA
10. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
11. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2
...ION OF VARIOUS FINANCIAL AND RESTRUCTURING ALTERNA...ire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (...rmaceutical and medical device company, today anno...anagement (Ares) and New Leaf Venture Partners (Ne...e Purchase Agreement dated July 7, 2008. Angiotech...
...GO, Nov. 21 Gen-Probe,s (Nasdaq: GPRO ),CE-mark...ecular tool to more,accurately detect high-risk hu...iated with cervical cancer or precancerous lesions...entific posters presented last week by,independent...nference of the,European Research Organization on ...
...FF LAKE, N.J., Nov. 20 Par Pharmaceutical Compani....S. District Court for the District of New Jersey ...tion for a temporary restraining order (TRO) halti...budesonide inhaled solution). In conjunction with...d and that it too would halt all sales of its auth...
Other Biology Technology:Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 2Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 4Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 2Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 3Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 4Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 5Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How to read brain activity? 2New therapy targets for amyloid disease 2Climbing to new heights in the forest canopy 9503 1Climbing to new heights in the forest canopy 9503 2Sperm Cell Insights May Aid Stem Cell Research 53867 1Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 1Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 2Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 3
...cher has found that sick female deer mice devote t...isa Schwanz, a researcher in the department of eco...e size of offspring for both infected and healthy ... with a parasite produced larger offspring than he...use most mammals tend to focus on their own surviv...
... Amyloid deposits in tissues and organs are linked...rkinsons, type II diabetes, and prion diseases suc...cal substances; they have potential as a nanomater...ecular assemblies exceed those of synthetic polyme...n the journal Angewandte Chemie, since the buildin...
...ission has awarded 4.5 million to a pan-European c...opes biological data resources into a sustainable,...ciences. The European Life-science Infrastructure ... by the European Molecular Biology Laboratorys Eur...lves 32 partners from 13 countries. The consortium...
Other Biology News:Mice mothers devote energies to offspring when life is threatened 2Protein fibrils as alternative plastics? 2Securing the future of Europe's biological data resources 2
Mouse Anti-Human B-Cells (FMC7 Antigen) Monoclonal Antibody, FITC Conjugated from AbD Serotec
... boxes are ideal for use in refrigerators, freezer...arious storage racks. Four vibrant colors allow fo...n the bottom allow liquid nitrogen drainage or pro....7 mm cell) grid which holds 81 tubes. Box dimen...
Rabbit Anti-PARATHION Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Bacterial HISTIDASE Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: